A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.
dc.contributor.author | Millstein, Joshua | en |
dc.contributor.author | Budden, Timothy | en |
dc.contributor.author | Anglesio, Michael | en |
dc.contributor.author | Talhouk, Aline | en |
dc.contributor.author | Beeghly-Fadiel, Alicia | en |
dc.contributor.author | Berchuck, Andrew | en |
dc.contributor.author | Chenevix-Trench, Georgia | en |
dc.contributor.author | deFazio, Anna | en |
dc.contributor.author | Fasching, Peter A | en |
dc.contributor.author | Gayther, Simon | en |
dc.contributor.author | Garcia, Maria | en |
dc.contributor.author | Goode, Ellen L | en |
dc.contributor.author | Henderson, Michelle | en |
dc.contributor.author | Konecny, Gottfried E | en |
dc.contributor.author | Orsulic, Sandra | en |
dc.contributor.author | Huntsman, David | en |
dc.contributor.author | Bowtell, David | en |
dc.contributor.author | Doherty, Jennifer | en |
dc.contributor.author | Pharoah, Paul | en |
dc.contributor.author | Ramus, Susan J | en |
dc.date.accessioned | 2020-12-17T00:30:25Z | |
dc.date.available | 2020-12-17T00:30:25Z | |
dc.date.issued | 2018-05-20 | en |
dc.identifier.issn | 0732-183X | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/315175 | |
dc.rights | All rights reserved | |
dc.rights.uri | ||
dc.title | A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer. | en |
dc.type | Conference Object | |
prism.issueIdentifier | 15 | en |
prism.publicationDate | 2018 | en |
prism.publicationName | JOURNAL OF CLINICAL ONCOLOGY | en |
prism.volume | 36 | en |
dc.identifier.doi | 10.17863/CAM.62283 | |
rioxxterms.versionofrecord | 10.1200/JCO.2018.36.15_suppl.5583 | en |
rioxxterms.version | AM | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | en |
rioxxterms.licenseref.startdate | 2018-05-20 | en |
dc.contributor.orcid | Pharoah, Paul [0000-0001-8494-732X] | |
dc.identifier.eissn | 1527-7755 | |
rioxxterms.type | Conference Paper/Proceeding/Abstract | en |
pubs.funder-project-id | Cancer Research UK (16561) | |
pubs.funder-project-id | National Institutes of Health (NIH) (via H Lee Moffitt Cancer Center & Research Institute) (SUBAWARD # 10-15915-01-03-G2) | |
pubs.funder-project-id | Congressionally Directed Medical Research Programs (CDMRP) (via (BD521555) | |
pubs.funder-project-id | National Institutes of Health (NIH) (via Cedars-Sinai Medical Center) (sub award 0001331845) | |
pubs.funder-project-id | H. Lee Moffitt Cancer Center & Research Institute (8604) |
Files in this item
This item appears in the following Collection(s)
-
Cambridge University Research Outputs
Research outputs of the University of Cambridge